LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill hopes to shrink lung tumors in early trial
Disease control Recruiting nowThis early-stage study tests a new tablet, AST2303, in 120 adults with advanced non-small cell lung cancer that has spread. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors or slow the disease. Participants take the pill and are …
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 08:18 UTC
-
New hope for advanced cancers: experimental drug enters human trials
Disease control Recruiting nowThis study tests an experimental drug called PF-07248144 in people with advanced breast, prostate, or lung cancer that has spread and no longer responds to standard treatments. The goal is to see if the drug is safe and can shrink or control tumors. About 320 participants will re…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 08:17 UTC
-
New hope for advanced lung cancer: experimental combo therapy enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug, SHR2554, combined with other cancer treatments for people with advanced non-small cell lung cancer that cannot be removed by surgery or has spread. The goal is to see if the combination is safe and shrinks tumors. About 200 adults aged 18-75 with good…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New hope for HER2-positive lung cancer: targeted drug plus immunotherapy enters human testing
Disease control Recruiting nowThis study tests a targeted cancer drug (trastuzumab deruxtecan) combined with immunotherapy, with or without chemotherapy, as a first treatment for people with advanced non-small cell lung cancer that has high levels of a protein called HER2. The main goal is to check safety and…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 11, 2026 20:50 UTC